Leelyn Smith, LLC Bristol Myers Squibb CO Transaction History

Leelyn Smith, LLC

$549 Million
Q1 2025

A detailed history of Leelyn Smith, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Leelyn Smith, LLC holds 47,267 shares of BMY stock, worth $2.21 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

47,267

Previous 47,699 0.91%

Holding current value

$2.21 Million

Previous $2.7 Million 6.86%

% of portfolio

0.52%

Previous 0.49%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$53.9 - $63.11 $23,284 - $27,263	-432 Reduced 0.91%	47,267 $2.88 Million
Q4 2024 Feb 10, 2025	BUY	$51.92 - $59.94 $11,162 - $12,887	215 Added 0.45%	47,699 $2.7 Million
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $157,727 - $205,809	3,977 Added 9.14%	47,484 $2.46 Million
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $200,525 - $263,996	4,982 Added 12.93%	43,507 $1.81 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $80,654 - $91,446	1,681 Added 4.56%	38,525 $2.09 Million
Q4 2023 Feb 08, 2024	BUY	$48.48 - $57.85 $29,330 - $34,999	605 Added 1.67%	36,844 $1.89 Million
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $37,686 - $42,139	651 Added 1.83%	36,239 $2.1 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $92,188 - $102,360	-1,447 Reduced 3.91%	35,588 $2.28 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $36,337 - $41,215	553 Added 1.52%	37,035 $2.57 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $146,684 - $173,694	2,142 Added 6.24%	36,482 $2.62 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $81,116 - $89,337	1,117 Added 3.36%	34,340 $2.64 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $59,820 - $71,729	973 Added 3.02%	33,223 $2.43 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $22,792 - $26,571	-425 Reduced 1.3%	32,250 $2.01 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $473 - $554	8 Added 0.02%	32,675 $1.93 Million
Q2 2021 Aug 31, 2021	BUY	$61.91 - $67.42 $31,574 - $34,384	510 Added 1.59%	32,667 $2.18 Million
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $52,100 - $58,597	878 Added 2.81%	32,157 $2.03 Million
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $25,925 - $29,378	-449 Reduced 1.42%	31,279 $1.94 Million
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $1.77 Million - $1.96 Million	30,808 Added 3348.7%	31,728 $1.91 Million
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $1.77 Million - $2.06 Million	-32,218 Reduced 97.22%	920 $1.9 Million
Q1 2020 May 06, 2020	BUY	$46.4 - $67.43 $99,806 - $145,041	2,151 Added 6.94%	33,138 $1.85 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $1.52 Million - $1.99 Million	30,987 New	30,987 $1.99 Million

Others Institutions Holding BMY

# of Institutions

2,806

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.6B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leelyn Smith, LLC with notifications on news.

Account